News
ALPMF
15.60
NaN%
--
Goldman Sachs Sticks to Its Buy Rating for Astellas Pharma (ALPMF)
TipRanks · 2d ago
Weekly Report: what happened at ALPMF last week (0420-0424)?
Weekly Report · 3d ago
Astellas Books Major Impairment and Extraordinary Losses in FY2025 Non-Consolidated Results
TipRanks · 3d ago
Astellas Pharma Announces New Board Slate and Governance Changes for 2026
TipRanks · 3d ago
Pfizer, Astellas win FDA priority review for Padcev in bladder cancer with Merck’s Keytruda
Seeking Alpha · 04/20 11:20
Weekly Report: what happened at ALPMF last week (0413-0417)?
Weekly Report · 04/20 09:56
Astellas Pharma (ALPMF) Receives a Hold from UBS
TipRanks · 04/16 10:59
Goldman Sachs Sticks to Its Buy Rating for Astellas Pharma (ALPMF)
TipRanks · 04/15 10:16
Weekly Report: what happened at ALPMF last week (0406-0410)?
Weekly Report · 04/13 09:58
Astellas’ Menopause Drug Fezolinetant Hits Key Safety Milestone in Japan
TipRanks · 04/08 16:30
Weekly Report: what happened at ALPMF last week (0330-0403)?
Weekly Report · 04/06 09:58
ORIC Pharma drops after early-stage trial data for prostate cancer therapy
Seeking Alpha · 04/01 11:46
Astellas Highlights R&D Strategy While Flagging Market and Development Risks
TipRanks · 03/31 01:31
Weekly Report: what happened at ALPMF last week (0323-0327)?
Weekly Report · 03/30 09:59
Jefferies Keeps Their Buy Rating on Astellas Pharma (ALPMF)
TipRanks · 03/24 10:19
J.P. Morgan Sticks to Its Hold Rating for Astellas Pharma (ALPMF)
TipRanks · 03/23 10:16
Weekly Report: what happened at ALPMF last week (0316-0320)?
Weekly Report · 03/23 09:55
Pfizer posts late-stage trial win for Talzenna plus Xtandi in new prostate cancer indication
Seeking Alpha · 03/19 11:44
Astellas Pharma (ALPMF) Receives a Hold from Mizuho Securities
TipRanks · 03/19 10:16
Macquarie Reaffirms Their Buy Rating on Astellas Pharma (ALPMF)
TipRanks · 03/16 10:36
More
Webull provides a variety of real-time ALPMF stock news. You can receive the latest news about Astellas Pharma through multiple platforms. This information may help you make smarter investment decisions.
About ALPMF
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.